Showing results (31-40 of 128) with videos related to
Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rateValérie Dutoit, Philippe Guillaume, Maha Ayyoub, et al.European Journal of Immunology|May 4, 2011
Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunitySophie R Sierro, Alena Donda, Rachel Perret, et al.Frontiers in Psychology|September 23, 2024
Validation of the French version of the Body Awareness Questionnaire: toward a way to assess alexisomiaArnaud Carre, Rebecca Shankland, Philippe Guillaume, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptideIsabelle Miconnet, Sylvain Koenig, Daniel Speiser, et al.Cancer Research|September 23, 2003
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patientsMaha Ayyoub, Donata Rimoldi, Philippe Guillaume, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Interactions of Ly49 family receptors with MHC class I ligands in trans and cisLéonardo Scarpellino, Franziska Oeschger, Philippe Guillaume, et al.Cancer Research|March 27, 2015
Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living CellsMichael Hebeisen, Julien Schmidt, Philippe Guillaume, et al.BMC Research Notes|November 25, 2023
Imiquimod-induced pruritus in female wild-type and knockin Wistar rats: underscoring behavioral scratching in a rat model for antipruritic treatmentsKaren Lariosa-Willingham, Dmitri Leonoudakis, Florian Simon, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Soluble MHC-peptide complexes induce rapid death of CD8+ CTLMarek Cebecauer, Philippe Guillaume, Pavel Hozák, et al.The Journal of Clinical Investigation|June 5, 2003
In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responsesChristoph Esslinger, Laurence Chapatte, Daniela Finke, et al.Pageof 13